Background Image
Table of Contents Table of Contents
Previous Page  32 / 66 Next Page
Information
Show Menu
Previous Page 32 / 66 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 32, No 3, May/June 2021

142

AFRICA

Unless stated otherwise, drugs and chemicals were obtained

from Sigma-Aldrich (SA). Streptozotocin (STZ) was used to

induce a moderate form of diabetes mellitus, as previously

described.

14

Rats were fasted of food (but not water) for six

hours to improve the uptake of STZ before being injected

intraperitoneally (i.p.) with STZ (50 mg/kg). The STZ was freshly

dissolved in 0.1 M citrate buffer (pH 4.5) before administration.

Blood glucose was measured from tail vein blood samples

obtained at similar times of the day using a glucometer

(Accu-Chek, Roche, SA).

14

Rats with a random blood glucose

concentration ≥ 15 mmol/l were considered diabetic.

Magnesium was administered as MgSO

4

(270 mg/kg, i.p.)

dissolved in normal saline.

15,16

The i.p. route was chosen for Mg

2+

to achieve more reliable uptake compared to oral administration

in water or food where the uptake may vary in diabetes due to

polydipsia and polyphagia.

The rats were randomly divided into four treatment groups,

and each rat was identified by a unique label on the tail. The

control group was injected i.p. with a single dose of citrate buffer

on the first day, and with saline i.p. once daily for 28 consecutive

days. The STZ group was injected i.p. with a single dose of STZ

50 mg/kg on the first day, and with saline i.p. once daily for 28

days. The STZ + Mg

2+

group was injected i.p. with a single dose

of STZ 50 mg/kg on the first day, and with MgSO

4

270 mg/kg

i.p. once daily for 28 days. The Mg

2+

group was injected i.p. with

a single dose of citrate buffer on the first day, and with MgSO

4

270 mg/kg i.p. once daily for 28 days.

Rat hearts were surgically removed under anaesthesia to

euthanise the rats, as previously described.

16

Briefly, rats were

anticoagulated with heparin (500 IU/kg, i.p.) and anaesthetised

with sodium pentobarbital (70 mg/kg, i.p., Vetserv, SA). Upon

loss of the pedal withdrawal reflexes, the hearts were excised via

a thoracotomy incision and placed in cold (4°C), filtered (7-

μ

m

pore Whatman filter paper, Sigma-Aldrich, SA), modified Krebs-

Henseleit (KH) solution containing (in mmol/l): 118.5 NaCl, 4.7

KCl, 25 NaHCO

3

, 1.2 MgSO

4

, 1.8 CaCl

2

, 1.2 KH

2

PO

4

and 11

glucose (pH 7.4). CaCl

2

was added after the optimisation of pH

to prevent precipitation of calcium with phosphate. Some hearts

were used for cardiac perfusion studies, whereas the others were

either histologically analysed or snap-frozen in liquid nitrogen and

stored at –80°C for Western blot analysis.

For perfusion studies, the hearts were retrogradely perfused

with K-H solution through an aortic cannula on a constant-

pressure (74 mmHg) Langendorff apparatus. To ensure optimal

cardiac tissue viability, the time lapse between excision of the

heart and commencement of perfusion was limited to three

minutes. The K-H solution was gassed with carbogen (95% O

2

and 5% CO

2

) and was maintained at 37°C. The coronary flow

rate was measured by collecting coronary effluent over time and

was normalised to heart weight. Blood samples used for Mg

2+

assays were collected at the time of removal of the heart and

centrifuged at 15 000

g

(Beckman microfuge, USA) to obtain

plasma, which was frozen until further analysis.

Electrocardiographic (ECG) and haemodynamic parameters

were measured using the PowerLab data-acquisition system

and LabChart Pro 7 software (ADInstruments, Australia), as

previously described.

16

ECG was recorded using apex-to-base

electrodes via a transducer (ML136) and was analysed using

the LabChart Pro ECG module (ADInstruments, Australia).

The QT interval, corrected for heart rate (QTc) was calculated

using Bazett’s formula. Left ventricular (LV) pressure was

measured using a water-filled, intraventricular balloon connected

to a pressure transducer (MLT1199) and amplifier (ML221,

ADInstruments, Australia).

The hearts were stabilised for 20 minutes and the LV

end-diastolic pressure (LVEDP) was set at 5–10 mmHg. The

LabChart 7 Pro blood pressure module (ADInstruments,

Australia) was used to analyse haemodynamic data and to derive

the maximal rate of pressure increase (+dP/dt

max

), the maximal

rate of pressure decline (–dP/dt

max

), contractility index and the

time constant of ventricular relaxation (

tau

). The LV developed

pressure (LVDP) was calculated as the difference between LV

peak systolic pressure and LVEDP.

Transverse sections of cardiac ventricular tissue were

stained with either haematoxylin and eosin (H&E) or Masson’s

trichrome, as previously described.

16

Histological images were

taken using a charge-coupled device camera (Zeiss AxioCam,

Germany) attached to an optical microscope (Zeiss AxioSkop,

Germany). The cardiomyocyte width on H&E images was

analysed using ImageJ software (NIH, USA). The average width

of five cells on each of four sections of the heart was calculated

for each heart. The degree of interstitial and perivascular fibrosis

on Masson’s trichrome images was semi-quantitatively scored, as

done previously,

16

based on a scoring system described by Buwa

et al

.

17

as follows: none (–), mild (+), moderate (++), and severe

(+++).

Frozen LV tissues were homogenised on ice by sonication

in a modified radioimmunoprecipitation assay buffer (50 mM

Tris-HCl, 150 mM NaCl, 1% Triton X-100, 0.5% sodium

deoxycholate, 0.1% sodium dodecyl sulphate, pH 7.4) containing

a protease/phosphatase inhibitor cocktail (Thermo Scientific,

USA). Protein concentrations were quantified (Pierce protein

assay kit, Thermo Scientific, USA) and protein samples (40

µg) were loaded and electrophoresed on 12% sodium dodecyl

sulphate-polyacrylamide gels (Mini-Protean Tetra Cell, BioRad,

SA) and transferred to isopropanol-soaked polyvinylidene

fluoride membranes (Trans-Blot Turbo, Bio-Rad, SA).

The membranes were blocked with 5% bovine serum albumin

(BSA) in 0.1% Tween20 phosphate-buffered saline (PBS-T) for

one hour at room temperature, and incubated with anti-ATP5A

mouse antibody (1:5000, #136178, Santa Cruz Biotechnology,

USA) in 5% BSA in PBS-T overnight at 4°C. The primary

antibody was excluded in the negative control in order to rule out

non-specific binding of the secondary antibody. The membranes

were washed with PBST and incubated with horseradish

peroxidase-conjugated secondary antibody (1:10000, #170-6516,

Bio-Rad, SA) in 5% BSA in PBS-T for two hours at room

temperature.

The membranes were then washed with PBS-T, incubated

with enhanced chemiluminescence substrate (Bio-Rad, SA)

and exposed to X-ray film in the dark room. The membranes

were stripped, blocked and re-probed with anti-

β

-actin rabbit

antibody (1:10000, #16039, Abcam, USA) and goat anti-rabbit

secondary antibody (1:10 000, #6721, Abcam, USA). The bands

on films were analysed using ImageJ software (NIH, USA) and

were normalised to those of the housekeeping protein

β

-actin.

The Mg

2+

concentration was measured in the plasma samples

prepared at exsanguination, 18–24 hours after the final dose

of MgSO

4

had been administered. Ionised Mg

2+

concentration

was measured using automated spectrophotometric and